ACADIA Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.

About ACAD

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.

CEO

Stephen R. Davis

CEOStephen R. Davis

Employees

598

Employees598

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1993

Founded1993

Employees

598

Employees598

ACAD Key Statistics

Market cap

2.81B

Market cap2.81B

Price-Earnings ratio

-44.84

Price-Earnings ratio-44.84

Dividend yield

—

Dividend yield—

Average volume

1.44M

Average volume1.44M

High today

$17.58

High today$17.58

Low today

$17.03

Low today$17.03

Open price

$17.44

Open price$17.44

Volume

1.16M

Volume1.16M

52 Week high

$33.99

52 Week high$33.99

52 Week low

$16.16

52 Week low$16.16

ACAD News

Yahoo Finance 12h

Insider Sale: CEO Stephen Davis Sells Shares of ACADIA Pharmaceuticals Inc - Yahoo Finance

On May 2, 2024, Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), sold 11,427 shares of the company. The transaction was filed on the same day...

Yahoo Finance 3d

Acadia Pharmaceuticals Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Wall Street expects a year-over-year increase in earnings on higher revenues when Acadia Pharmaceuticals (ACAD) reports results for the quarter ended March 2024...

Benzinga 4d

ACADIA Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (25 Ratings) - ACADIA Pharmaceuticals - Benzinga

Loading... Loading... ACADIA Pharmaceuticals ACAD has been analyzed by 25 analysts in the last three months, revealing a diverse range of perspectives from bul...

Analyst ratings

71%

of 21 ratings

Buy

71.4%

Hold

23.8%

Sell

4.8%

More ACAD News

Yahoo Finance 5d

Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship - Yahoo Finance

-- 10 academic scholarships awarded supporting siblings of Rett syndrome patients SAN DIEGO, April 29, 2024--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasd...

Simply Wall St 6d

ACADIA Pharmaceuticals shareholders have endured a 37% loss from investing in the stock five years ago

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But every investor is virtually...